2024 - Using Real-World Evidence To Enhance Drug Development: Arterial Health Monitoring Innovations

As the pharmaceutical industry increasingly turns to real-world evidence to support drug development and regulatory decisions, the importance of accurate and comprehensive health monitoring cannot be overstated.
Arterial health is a key determinant of the effectiveness and safety of many therapies, particularly in the context of cardiovascular disease, diabetes and other chronic conditions. Central blood pressure and arterial stiffness serve as robust biomarkers for assessing the impact of new drugs on the vascular system, providing insights that traditional peripheral measurements cannot offer.
CONNEQT Pulse empowers pharmaceutical companies to collect precise RWE, facilitating more informed decisions in the drug development process from early-phase trials to post-market surveillance.
It is a cuff-based device that monitors arterial health through central blood pressure and pulse wave analysis (PWA), thus representing a significant advancement in this area. This webinar will explore how CONNEQT Pulse can be integrated into clinical trials and real-world studies to generate critical RWE that informs drug efficacy and safety profiles.
This webinar will provide a detailed look at the application of CONNEQT Pulse in drug development, its validation as a clinical tool and its potential to improve therapeutic outcomes through better-informed regulatory strategies.
Register for this webinar to discover how gathering real-world evidence can revolutionize drug development for cardiovascular diseases.
Keywords: Cardiovascular Disease, Drug Development, Clinical Research, Biomarkers, Real-World Evidence, Clinical Data, Regulatory, Therapeutic Areas, RWE, Commercialization/HEOR/Market Access